Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Then and Now

Then and Now

posted on Oct 28, 2008 08:22AM

I have to say that when I first invested in to PTSC, it was to capitalize on the MMP. Since then the emphasis seems to have shifted to becoming a more traditional company; which is good in a way when you want to have consistent income; hopefully be able to forecast your business quarter to quarter; and actually be in a better position to control your future, as opposed to see'ing what the MMP licensing brings in month to month and quarter to quarter.

But at the same time, I think the MMP has the potential to bring in more and bigger chunks of income sooner than ramping up production in a traditional company. I guess what I'm trying to say is that I'm still looking to the MMP to make us some real money. It's great that PTSC is working on becoming a more traditional company. But when I invested in this company I was counting on licensing income. The company that PTSC is becoming today didn't exist then. The company that PTSC is becoming has potential, but that is not the reason I invested in this company.

So I say, more MMP income in the near to medium term. A more tradional income in the long run...

- 67GTO

Share
New Message
Please login to post a reply